Holen Sie sich die Stockscreener-App
85.24
0.05%
0.04
Handel nachbörslich:
85.41
0.17
+0.20%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$85.20
Offen:
$84.82
24-Stunden-Volumen:
4.38M
Relative Volume:
1.46
Marktkapitalisierung:
$40.49B
Einnahmen:
$5.83B
Nettoeinkommen (Verlust:
$261.52M
KGV:
157.21
EPS:
0.5422
Netto-Cashflow:
$1.32B
1W Leistung:
+3.26%
1M Leistung:
+10.80%
6M Leistung:
+25.33%
1J Leistung:
+31.26%
1-Tages-Spanne:
$84.06
$86.19
1-Wochen-Bereich:
$82.38
$87.20
52-Wochen-Spanne:
$60.15
$87.20
Ventas Inc Stock (VTR) Company Profile
Firmenname
Ventas Inc
Sektor
Telefon
(312) 660-3800
Adresse
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, OHI, DOC, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
85.24 | 40.47B | 5.83B | 261.52M | 1.32B | 0.5422 |
|
WELL
Welltower Inc
|
210.72 | 144.97B | 10.83B | 961.84M | 1.88B | -0.7091 |
|
OHI
Omega Healthcare Investors Inc
|
47.40 | 13.90B | 1.08B | 448.00M | 779.91M | 1.61 |
|
DOC
Healthpeak Properties Inc
|
16.70 | 11.32B | 2.80B | -10.95M | 1.15B | -0.0564 |
|
AHR
American Healthcare Reit Inc
|
51.80 | 9.21B | 2.07B | -37.81M | 84.15M | -0.27 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | Goldman | Buy |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-09-19 | Eingeleitet | UBS | Neutral |
| 2025-06-23 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-03-07 | Hochstufung | Argus | Hold → Buy |
| 2025-01-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-02-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2024-01-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-07 | Hochstufung | Wedbush | Neutral → Outperform |
| 2023-10-11 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-10-03 | Eingeleitet | Wedbush | Neutral |
| 2023-09-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-01 | Bestätigt | Credit Suisse | Outperform |
| 2022-11-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-23 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | CapitalOne | Overweight |
| 2022-05-18 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-12-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-22 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-09-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-08-26 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-06-15 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-13 | Hochstufung | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-11-30 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-11-10 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-09-08 | Herabstufung | Argus | Buy → Hold |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-08-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2020-08-14 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-03-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | Herabstufung | Jefferies | Buy → Underperform |
| 2020-02-28 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | Hochstufung | Jefferies | Hold → Buy |
| 2019-12-20 | Fortgesetzt | Mizuho | Neutral |
| 2019-12-10 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | Hochstufung | Argus | Hold → Buy |
| 2019-10-30 | Herabstufung | Stifel | Buy → Hold |
| 2019-10-28 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Ventas Inc Aktie (VTR) Neueste Nachrichten
Varma Mutual Pension Insurance Co Has $11.24 Million Stake in Ventas, Inc. $VTR - MarketBeat
Is Ventas Inc. showing insider buying2025 AllTime Highs & Short-Term Trading Opportunity Alerts - mfd.ru
Ventas (NYSE:VTR) EVP Carey Roberts Sells 35,532 Shares - MarketBeat
Metis Global Partners LLC Acquires 26,080 Shares of Ventas, Inc. $VTR - MarketBeat
Rhumbline Advisers Lowers Holdings in Ventas, Inc. $VTR - MarketBeat
Krilogy Financial LLC Purchases New Holdings in Ventas, Inc. $VTR - MarketBeat
Cibc World Market Inc. Grows Position in Ventas, Inc. $VTR - MarketBeat
Ventas (NYSE:VTR) Hits Trailing High, Tracks S&P 500 Index Moves - Kalkine Media
Ventas outlines 13–17% SHOP NOI growth target for 2026 while expanding senior housing investments - MSN
Will Ventas Inc. benefit from rising consumer demandJuly 2025 PreEarnings & Risk Managed Investment Strategies - mfd.ru
Ventas (NYSE:VTR) Reaches New 12-Month HighHere's Why - MarketBeat
Candriam S.C.A. Has $3.25 Million Position in Ventas, Inc. $VTR - MarketBeat
Stop Loss: Is Ventas Inc forming a breakout patternQuarterly Portfolio Review & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Ventas, Welltower See Growth Amid Senior Housing Push - Law360
RBC Capital Keeps Their Buy Rating on Ventas (VTR) - The Globe and Mail
Citigroup Adjusts Ventas Price Target to $96 From $88, Maintains Buy Rating - marketscreener.com
Citi Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $96 - 富途牛牛
Ventas, Inc. $VTR Shares Sold by Impax Asset Management Group plc - MarketBeat
KeyBanc raises Ventas stock price target to $90 on strong rent growth By Investing.com - Investing.com Australia
Argus Research Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $88 - 富途牛牛
KeyBanc raises Ventas stock price target to $90 on strong rent growth - Investing.com UK
Gainers Report: What are the risks of holding Ventas IncPortfolio Value Report & Technical Buy Zone Confirmations - baoquankhu1.vn
Charter Senior Living Expands Portfolio with Management of Two Ventas Communities - Senior Living News
Ventas' Growth, Investments in Senior Housing May Lift Earnings, RBC Says - marketscreener.com
Ventas price target raised to $88 from $80 at Argus - TipRanks
Analysts’ Opinions Are Mixed on These Real Estate Stocks: Ventas (VTR) and Park Hotels & Resorts (PK) - The Globe and Mail
Ventas price target raised to $91 from $83 at RBC Capital - TipRanks
Ventas (VTR): KeyBanc Raises Price Target to $90 Following Overw - GuruFocus
Ventas (NYSE:VTR) Price Target Raised to $90.00 - MarketBeat
RBC Raises Price Target on Ventas to $91 From $83, Keeps Outperform Rating - marketscreener.com
Argus Adjusts Price Target on Ventas to $88 From $80, Maintains Buy Rating - marketscreener.com
A Quick Look at Today's Ratings for Ventas Inc(VTR.US), With a Forecast Between $85 to $93 - 富途牛牛
KeyBanc Adjusts Price Target on Ventas to $90 From $85, Maintains Overweight Rating - marketscreener.com
RBC Thinks Ventas Can Keep Growing Senior Housing Fast - Finimize
Goldman Sachs Adjusts Price Target on Ventas to $100 From $94, Maintains Buy Rating - marketscreener.com
36 U.S. REITs Expected To Raise Dividends In Q1 2026 - Seeking Alpha
Ventas, Inc. (VTR) Reports Strong 2025 Growth, Accelerates Senior Housing Investments - Insider Monkey
BofA Securities Maintains Ventas Inc(VTR.US) With Buy Rating, Maintains Target Price $91 - 富途牛牛
Ventas Inc. Earnings Call Highlights SHOP-Driven Surge - TipRanks
Goldman Sachs REIT Stocks: Top 12 Stock Picks - Insider Monkey
Ventas stock price target raised to $100 by Goldman Sachs on acquisition momentum - Investing.com
Goldman Sachs Raises Ventas Price Target to $100 From $94 - marketscreener.com
Beyond The Numbers: 4 Analysts Discuss Ventas Stock - Benzinga
Cantor Fitzgerald Maintains Ventas Inc(VTR.US) With Buy Rating, Maintains Target Price $93 - 富途牛牛
Why Ventas (VTR) Is Up 6.6% After Dividend Hike And 2026 Earnings Guidance And What's Next - simplywall.st
UBS Adjusts Ventas Price Target to $85 From $82, Maintains Neutral Rating - marketscreener.com
Ventas amends ATM sales agreement, increases available common stock to $2.5 billion By Investing.com - Investing.com South Africa
Cantor Fitzgerald reiterates Overweight rating on Ventas stock at $93 By Investing.com - Investing.com South Africa
UBS Maintains Ventas Inc(VTR.US) With Hold Rating, Raises Target Price to $85 - 富途牛牛
Ventas amends ATM sales agreement, increases available common stock to $2.5 billion - Investing.com Nigeria
Cantor Fitzgerald reiterates Overweight rating on Ventas stock at $93 - Investing.com
Finanzdaten der Ventas Inc-Aktie (VTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.77%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):